Suscribirse

PRENATAL DIAGNOSIS : Therapeutic Implications - 08/09/11

Doi : 10.1016/S0094-0143(05)70005-7 
Pramod P. Reddy, MD a, James Mandell, MD, FACS, FAAP b
a Division of Pediatric Urology, The Hospital for Sick Children, Toronto, Ontario, Canada (PPR) 
b Division of Urology, Albany Medical College, Albany, New York (JM) 

Resumen

Congenital anomalies occur in 2% to 3% of all neonates and are a major cause of perinatal morbidity and mortality. Prenatal ultrasonography can detect most fetal malformations. Current diagnostic capabilities can identify urinary tract anomalies as early as 12 to 14 weeks of gestation.9 The detection rate of urologic abnormalities with prenatal ultrasonography ranges from 84.4%56 to 97%.17 The ability to diagnose abnormalities of the fetal urinary tract with the widespread use of routine obstetric ultrasound examinations has contributed to the growth of perinatal urology. Contemporary ultrasonographic techniques cannot directly confirm the existence of obstruction, a physiologic attribute, but rather demonstrate dilation as an imaging characteristic only. Current understanding of the pathophysiology of obstructive uropathy is incomplete, and there is considerable controversy in regards to what constitutes clinically significant obstruction and in regards to the indications and optimal timing of surgical intervention in the management of prenatally diagnosed cases of ureteropelvic junction (UPJ) obstruction.

Increased information on antenatally detected asymptomatic UPJ obstruction has altered the understanding of the natural history of this condition. In the past, most patients presented with symptoms such as urosepsis, pain, hematuria, a palpable mass, or failure to thrive such that the need for treatment was apparent. However, the management of incidentally detected hydronephrosis continues to evolve. It is now apparent that not all urinary tract dilatation is secondary to mechanical obstruction but may simply be the result of an atonic collecting system.43

Initial experimental and clinical evidence suggested that early relief of congenital urinary obstruction was associated with a significantly greater return of renal function through recruitment of immature nephrons in the peripheral cortical zone.24 This concept was supported by evidence showing that renal development continues throughout infancy, with glomerular filtration rate (GFR) and creatinine clearance reaching adult levels by the age of 2 years. Conservative management of these incidentally detected anomalies has become the standard of care, with no long-term loss of measurable renal function in the majority of cases.48

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to James Mandell, MD, FACS, FAAP, Dean, Albany Medical College, A-34, 47 New Scotland Avenue, Albany, NY 12208


© 1998  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 25 - N° 2

P. 171-180 - mai 1998 Regresar al número
Artículo precedente Artículo precedente
  • THE PATHOPHYSIOLOGY OF UPJ OBSTRUCTION : Current Concepts
  • John M. Park, David A. Bloom
| Artículo siguiente Artículo siguiente
  • NEONATAL MANAGEMENT OF UNILATERAL HYDRONEPHROSIS : Role for Delayed Intervention
  • Stephen A. Koff

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.